Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Operating Activities
Net income (loss)	$ 7,735	$ (21,954)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation and amortization, net of accretion	6,722	4,734
(Increase) decrease in cash surrender value of BOLI	915	(457)
Net realized investment (gains) losses	(8,849)	28,673
Share-based compensation	1,031	1,011
Deferred income tax expense (benefit)	(2,272)	(10,224)
Policy acquisition costs, net of amortization (net deferral)	(420)	(599)
Equity in (earnings) loss of unconsolidated subsidiaries	(6,788)	1,562
Distributed earnings from unconsolidated subsidiaries	5,658	1,585
Other	(661)	(703)
Other changes in assets and liabilities:
Premiums receivable	(9,165)	(22,442)
Reinsurance related assets and liabilities	(12,290)	(4,623)
Other assets	13,151	14,268
Reserve for losses and loss adjustment expenses	21,071	(15,478)
Unearned premiums	13,699	30,202
Other liabilities	(837)	(17,604)
Net cash provided (used) by operating activities	28,700	(12,049)
Purchases of:
Fixed maturities, available-for-sale	(342,197)	(227,503)
Equity investments	(38,232)	(23,136)
Other investments	(33,252)	(6,065)
Investment in unconsolidated subsidiaries	(5,319)	(17,180)
Proceeds from sales or maturities of:
Fixed maturities, available-for-sale	195,266	180,698
Equity investments	82,048	157,652
Other investments	12,026	6,026
Net sales or (purchases) of fixed maturities, trading	3,163	(407)
Return of invested capital from unconsolidated subsidiaries	17,618	1,481
Net sales or maturities (purchases) of short-term investments	56,836	(7,441)
Unsettled security transactions, net change	27,025	12,656
Purchases of capital assets	(1,243)	(2,750)
Other	0	(2,206)
Net cash provided (used) by investing activities	(26,261)	71,825
Financing Activities
Repayments of Mortgage Loans	(390)	(376)
Dividends to shareholders	(2,686)	(16,714)
Capital contribution received from (return of capital to) external segregated portfolio cell participants	(53)	204
Other	(257)	(1,090)
Net cash provided (used) by financing activities	(3,386)	(17,976)
Increase (decrease) in cash and cash equivalents	(947)	41,800
Cash and cash equivalents at beginning of period	215,782	175,369
Cash and cash equivalents at end of period	214,835	217,169
Significant Non-Cash Transactions
Dividends declared and not yet paid	$ 2,699	$ 16,691